The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
07/24/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
RFA-CA-09-504
Opportunity Category:
Discretionary
Posted Date:
Jul 24, 2009
Creation Date:
Jul 24, 2009
Original Closing Date for Applications:
Nov 17, 2009
Current Closing Date for Applications:
Nov 17, 2009
Archive Date:
Dec 18, 2009
Funding Instrument Type:
Cooperative Agreement
Category of Funding Activity:
Education
Health
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
$8,750,000
Award Ceiling:
Award Floor:
CFDA Number(s):
93.394
--
Cancer Detection and Diagnosis Research
93.395
--
Cancer Treatment Research
93.396
--
Cancer Biology Research
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
Other Eligible Applicants include the following:
Regional Organizations.
Agency Name
National Institutes of Health
Description
Purpose. This limited competition Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits renewal applications for the support of the Cooperative Group Banks (CGBs). CGBs were established to collect, store, and distribute well-annotated human specimens from patients with cancer who are participating in NCI-funded Phase III and large Phase II clinical treatment trials. This FOA is designed to continue support of the infrastructure of the CGBs and to provide access for qualified investigators to the specimens with associated high-quality, clinical, treatment and outcome data that are critical for developing and validating biomarkers for diagnoses, prognoses, and predictions of responses of cancer patients to therapies.
